VIYASH SCIENTIFIC LIMITED
VIYASH · General/Diversified · NSE
₹252
Current Market Price
Fair Value (DCF)
₹158
Discount to FV
-37.4%
Updated just now
YieldIQ Score
50/100
Piotroski F-Score
7/9
Economic Moat
None
Confidence
34%
ROE
2.8%
Debt/Equity
0.62
WACC
11.1%
Market Cap
₹11,012 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
13.3%
Return on capital employed
EV / EBITDA
29.1×
Enterprise multiple
Debt / EBITDA
1.4×
Leverage vs earnings
Interest Coverage
1.8×
EBIT covers interest
Current Ratio
1.73×
Short-term liquidity
Asset Turnover
—
Revenue per ₹ of assets
Revenue CAGR (3Y)
34.1%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹252.3
Bear case
Discount -144.4%
Base case
Discount -59.7%
Bull case
Discount -17.5%
Ratio Trends
VIYASH · last 8 annual periods
ROE
2.8%
ROCE
13.3%
Operating Margin
—
Debt / Equity
0.62×
PE
—
EV / EBITDA
—
Historical Financials
VIYASH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1410 Cr | ₹1418 Cr | ₹1366 Cr | ₹3007 Cr | ₹3420 Cr | +24.8% |
| EBITDA | ₹118 Cr | ₹-52.2 Cr | ₹53.3 Cr | ₹338 Cr | ₹652 Cr | +53.3% |
| EBIT | ₹69.2 Cr | ₹-102 Cr | ₹-6.6 Cr | — | — | — |
| PAT | ₹41.0 Cr | ₹-121 Cr | ₹-35.9 Cr | ₹23.2 Cr | ₹177 Cr | +44.2% |
| EPS (diluted) | ₹1.65 | ₹-4.88 | ₹-1.44 | — | — | — |
| CFO | ₹30.6 Cr | ₹16.8 Cr | ₹30.6 Cr | ₹345 Cr | ₹323 Cr | +80.2% |
| CapEx | ₹-32.5 Cr | ₹-86.2 Cr | ₹-30.8 Cr | ₹-108 Cr | ₹-135 Cr | — |
| FCF | ₹-1.9 Cr | ₹-69.4 Cr | ₹-0.2 Cr | ₹237 Cr | ₹188 Cr | — |
| Total Assets | ₹1451 Cr | ₹1529 Cr | ₹1540 Cr | ₹1602 Cr | ₹4628 Cr | +33.6% |
| Total Debt | ₹365 Cr | ₹444 Cr | ₹488 Cr | ₹481 Cr | ₹490 Cr | +7.6% |
| Shareholders' Equity | ₹692 Cr | ₹699 Cr | ₹657 Cr | ₹704 Cr | ₹2911 Cr | +43.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
VIYASH vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 STAR STRIDES PHARMA SCI LTD | +46.0% | 50 | Data Limited | 20.0% | — |
 AKUMS AKUMS | — | — | Pending | 7.7% | — |
PGHL PGHL | — | — | Pending | 3.1% | — |
 SHILPAMED SHILPAMED | — | — | Pending | 3.3% | — |
SUDEEPPHRM SUDEEPPHRM | — | — | Pending | 28.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for VIYASH in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. VIYASH SCIENTIFIC LIMITED (VIYASH.NS) trades at 252.30 vs a model fair value of 158.02, a gap of -37.4%. Piotroski F-score: 7/9. Moat lab...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of VIYASH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for VIYASH →
Compare
Head-to-head with peers
Compare VIYASH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse VIYASHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.